Mylan buys rights to Israel-developed Multiple Sclerosis treatment | Times of Israel MS drug developed by Mapi Pharma requires a once-monthly injection instead of 3 times a week HIER WEITERLESEN: WWW.TIMESOFISRAEL.COM
‚Revitalized‘ PA includes brazen terror supporters – By including open supporters of terrorism in its new government, the Palestinian Authority is making a mockery of the U.S. demand for “revitalization.” | JNS.org 04.04.2024
Outrageous lie: Israeli hostages in Gaza „left happy and laughing“ – they received „generous treatment“ – PA TV interview | PMW Analysis 05.04.2024
Japan resumes funding to UNRWA for its ‚indispensable‘ aid work in Gaza – Sixth-biggest donor to UN agency for Palestinians lifts moratorium on payments, plans to release some $35 million of originally allocated funding | The Times of Israel 02.04.2024
Hinterlasse eine Antwort
Sie müssen... (sein)angemeldet sein um einen Kommentar zu schreiben.